Gene: TBC1D12
Official Full Name: TBC1 domain family member 12provided by HGNC
Gene Summary: Predicted to enable GTPase activator activity. Predicted to be involved in regulation of autophagosome assembly. Predicted to be located in endosome. Predicted to be active in autophagosome and recycling endosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29663 | TBC1D12 Knockout cell line (HeLa) | Human | TBC1D12 | 1:3~1:6 | Negative | Online Inquiry |
KO29664 | TBC1D12 Knockout cell line (HCT 116) | Human | TBC1D12 | 1:2~1:4 | Negative | Online Inquiry |
KO29665 | TBC1D12 Knockout cell line (HEK293) | Human | TBC1D12 | 1:3~1:6 | Negative | Online Inquiry |
KO29666 | TBC1D12 Knockout cell line (A549) | Human | TBC1D12 | 1:3~1:4 | Negative | Online Inquiry |
TBC1D12 Gene Knockout Cell Lines represent a breakthrough in functional genomics and cellular biology, providing researchers with a powerful tool to study the role of the TBC1D12 gene in various biological processes. These cell lines are engineered to have a complete knockout of the TBC1D12 gene, enabling the investigation of its contributions to intracellular signaling, cell growth, and metabolic regulation. By utilizing CRISPR-Cas9 gene-editing technology, we ensure precise and efficient gene disruption, allowing for reliable replication of results across experimental conditions.
The key functions of TBC1D12 are associated with the regulation of Rab GTPases, which play a pivotal role in intracellular transport and vesicle trafficking. The knockout cell lines offer a unique opportunity to dissect the molecular pathways that underlie these processes, providing insights into diseases where TBC1D12 may be implicated. Research into this gene is particularly significant in cancer biology and metabolic disorders, where altered intracellular signaling can lead to tumor progression or dysregulated metabolism.
One of the principal advantages of our TBC1D12 Gene Knockout Cell Lines is their validated performance in a variety of assays, enabling seamless integration into existing workflows. Unlike traditional models that may yield inconsistent results due to background expression, these knockout lines provide a clean system for thorough investigation. Moreover, they are compatible with high-throughput screening methods, making them an ideal choice for laboratories aiming to enhance their research efficiency.
The value of these cell lines extends beyond their technical specifications; they empower researchers and clinicians to uncover new therapeutic strategies and diagnostic markers linked to TBC1D12. Given the growing importance of gene function studies in personalized medicine, our product stands out for its scientific robustness and adaptability in various research contexts.
Our company prides itself on its commitment to developing cutting-edge biological products, backed by extensive expertise in genetic modification techniques. We ensure that our offerings support the scientific community in advancing knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.